AuriGen Medical

About AuriGen Medical

AuriGen Medical is an Irish electrophysiology and structural heart company dedicated to transforming the management of longstanding persistent atrial fibrillation by developing the first cardiac implant to treat both the stroke and arrhythmia risk associated with this devastating condition.

Innovation

AuriGen Co-founder, Dr John Thompson & Director of Grants at Myriad Associates, Marc Greatrex had previously worked together on a successful grant application with Marc having helped John & AuriGen successfully apply for Horizon 2020's SME instrument call back in 2018

Recognising the value that a successful grant bid writer brings to the application, Dr John approached Marc to help them prepare an application for Horizon 2020's Fast Track to Innovation funding call 6 months after they'd been granted their SME funding.

How we helped

Dr John and the team recognised that the grant bid writer is not an expert in their area and so the team at AuriGen ensured they relayed the passion, enthusiasm and science behind their innovation to Marc and the grant bid writing team.

"The role of the grant writer is to take our information and make it easy for us to score as high as possible when it's assessed by the examiners, and for us it's been critical because it's very fine margins in terms of the competition."

The reward

AuriGen ranked 1st overall in Europe for the FTI funding call and the company gained a lot of positive publicity from their success.

Their success opened doors to potential investors, business partners, physicians and now since their success everyone wants to know their "secret sauce" with Dr John admitting that "first & foremost it's important to have a compelling business and be doing something important and secondly, you need a fantastic grant writer like Marc"